Silva A, Lopes C, Carvalho Júnior C, Thomé R, dos Santos H, Reis R, et al. WIN55,212-2 induces caspase-independent apoptosis on human glioblastoma cells by regulating HSP70, p53 and Cathepsin D. Toxicol In Vitro. 2019;57:233-243 pubmed publisher

Huo J, Ma R, Chai X, Liang H, Jiang P, Zhu X, et al. Inhibiting a spinal cord signaling pathway protects against ischemia injury in rats. J Thorac Cardiovasc Surg. 2019;157:494-503.e1 pubmed publisher

Philippot G, Hallgren S, Gordh T, Fredriksson A, Fredriksson R, Viberg H. A Cannabinoid Receptor Type 1 (CB1R) Agonist Enhances the Developmental Neurotoxicity of Acetaminophen (Paracetamol). Toxicol Sci. 2018;166:203-212 pubmed publisher

Yuan J, Johnson R, Huang R, Wichterman J, Jiang H, Hayton K, et al. Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum. Nat Chem Biol. 2009;5:765-71 pubmed publisher

Nomura D, Blankman J, Simon G, Fujioka K, Issa R, Ward A, et al. Activation of the endocannabinoid system by organophosphorus nerve agents. Nat Chem Biol. 2008;4:373-8 pubmed publisher

Diamandis P, Wildenhain J, Clarke I, Sacher A, Graham J, Bellows D, et al. Chemical genetics reveals a complex functional ground state of neural stem cells. Nat Chem Biol. 2007;3:268-73 pubmed

Herzberg U, Eliav E, Bennett G, Kopin I. The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain. Neurosci Lett. 1997;221:157-60 pubmed

Pan X, Ikeda S, Lewis D. Rat brain cannabinoid receptor modulates N-type Ca2+ channels in a neuronal expression system. Mol Pharmacol. 1996;49:707-14 pubmed

Richter A, Loscher W. (+)-WIN 55,212-2, a novel cannabinoid receptor agonist, exerts antidystonic effects in mutant dystonic hamsters. Eur J Pharmacol. 1994;264:371-7 pubmed